대한부인종양학회

최신 논문

총 게시글 : 45

Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial 2026-06-24 VIEW : 2
Endometrial cancer: A Society of Gynecologic Oncology evidence-based review and recommendations, part II 2026-06-24 VIEW : 5
Endometrial cancer: A Society of Gynecologic Oncology evidence-based review and recommendations: Part I 2026-06-24 VIEW : 7
Prognostic role of immunohistochemical and molecular markers in no specific molecular profile endometrial cancer: a systematic review and meta-analysis exploratory analyses of the DUO- E/GOG-3041/ENGOT-EN10 trial. 2026-06-24 VIEW : 5
Endometrial Cancer: Prevalence, Characteristics, and Prognostic Implications, Results from the UTOLA Phase II GINECO Trial 2026-06-24 VIEW : 1
Biomarker heterogeneity and efficacy of durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib in patients with mismatch repair proficient endometrial cancer: exploratory analyses of the DUO-E/GOG-3041/ENGOT-EN10 trial 2026-06-24 VIEW : 3
Nivolumab and Ipilimumab in Advanced Mismatch Repair-Deficient/Microsatellite Instability-High Noncolorectal Cancers: A Nonrandomized Clinical Trial 2026-03-17 VIEW : 3
Fruquintinib plus sintilimab in patients with advanced endometrial cancer with mismatch-repair proficient status: a multicenter, single-arm, phase Ib/II trial 2026-03-17 VIEW : 2
Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trial 2026-03-17 VIEW : 3
Biomarker heterogeneity and efficacy of durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib in patients with mismatch repair proficient endometrial cancer: exploratory analyses of the DUO- E/GOG-3041/ENGOT-EN10 trial. 2026-03-17 VIEW : 5
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial 2026-03-17 VIEW : 9
Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775. 2026-03-17 VIEW : 7
A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer 2025-12-19 VIEW : 5
Pilot Study of Daily Exemestane in Women with Endometrial Intraepithelial Neoplasia or Low-Grade Endometrial Cancer 2025-12-19 VIEW : 3
Prognostic role of immunohistochemical and molecular markers in no specific molecular profile endometrial cancer: a systematic review and meta-analysis 2025-12-19 VIEW : 5

1
2
3